Biologics: Teriparatide and Newer Anabolics
1Harishchandra Institute of Orthopaedics & Research, Allahabad, India.
Indian Journal of Orthopaedics
|December 18, 2023
Summary
Biologic agents offer targeted osteoporosis treatments by addressing bone fragility mechanisms. Future research focuses on precision medicine, novel targets, and combination therapies for improved fracture prevention and quality of life.
Area of Science:
- Orthopedics
- Pharmacology
- Bone Biology
Background:
- Osteoporosis management has shifted from conventional therapies to advanced biologic agents.
- Biologics offer precision-driven strategies targeting the underlying mechanisms of bone fragility.
Purpose of the Study:
- To explore the mechanisms, applications, and future directions of biologic interventions in osteoporosis care.
- To provide a comprehensive overview of the evolving landscape of osteoporosis management.
Main Methods:
- Review of various biologic agents including Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL) inhibitors, sclerostin inhibitors, parathyroid hormone (PTH) analogues, and cathepsin K inhibitors.
- Discussion of potential benefits, limitations, safety, and combination therapies.
- Exploration of applications in specific patient populations, role of biomarkers, and novel targets.
Main Results:
- Biologic agents demonstrate targeted approaches to bone health, revolutionizing osteoporosis treatment.
- Combination therapies and tailored treatments based on patient characteristics show promise.
- Advancements in novel targets and drug delivery systems aim to enhance treatment effectiveness and convenience.
Conclusions:
- Biologic agents represent a significant advancement in osteoporosis management, offering personalized treatment strategies.
- Future directions include precision medicine, novel therapeutic targets, and combination therapies for enhanced fracture prevention.
- Continued research is anticipated to transform bone health outcomes and patient quality of life.
Related Concept Videos
01:17Hormones and Bone Tissue
2.7K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
2.7K
01:29Bone Disorders
3.5K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.5K
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
01:27Tumor Immunotherapy
529
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529
01:31Osteoclasts in Bone Remodeling
3.0K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.0K
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K